US$ 24.07
aod9604 side effects forum AOD 9604: Peptide Claims vs Clinical Reality AOD 9604 is marketed as a fat-metabolism peptide derived from a growth hormone fragment, often positioned as “HGH-like” without HGH's effects. The clinical question Peptides for Weight Loss: Types,
Description
Hypokalemia and thrombocytosis could occur upon conversion of severe megaloblastic anemia to normal erythropoiesis with methylcobalamin therapy

They proposed that NNMT may lead to obesity

Approach Short trial arm Duration 12 weeks Review Point Week 12 Notes METAOD005 used 12 weeks at oral doses 1-30 mg/day in 300 obese adults

B12 injections have different strengths, and knowing this helps us give the right dose